Mouse IL-18 Platinum ELISA

Also known as: Interleukin-18, Interferon-gamma-inducing factor

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS618/2*

Cat. No. Size
BMS618/2 96 tests
BMS618/2TEN 10 x 96 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Mouse IL-18 Platinum ELISA.

Click on image to view more information.

  • Data for Mouse IL-18 Platinum ELISA.
Description

Description: The mouse IL-18 ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of mouse IL-18. The mouse IL-18 ELISA is for research use only. Not for diagnostic or therapeutic procedures.

Formerly called interferon (IFN) gamma inducing factor (IGIF), IL-18 is a cytokine that plays an important role in the T-cell-helper type 1 (Th1) response, primarily by its ability to induce IFN gamma production in T cells and natural killer (NK) cells.
In terms of structure, IL-18 and IL-1 beta share primary amino acid sequences of the so-called ?signature sequence" motif and are similarly folded as all beta pleated sheet molecules. Also similar to IL-1 beta, IL- 18 is synthesized as a biologically inactive precursor molecule lacking a signal peptide which requires cleavage into an active, mature molecule by the intracellular cysteine protease called IL-1 beta-converting enzyme (ICE, caspase-1). The activity of the mature IL-18 is closely related to that of IL-1.
IL-18 induces gene expression and synthesis of tumor necrosis factor (TNF), IL-1, Fas Ligand, and several chemokines. The activity of IL-18 is via an IL-18 receptor (IL-18R) complex. IL-18 induces gene expression and synthesis of tumor necrosis factor (TNF), IL-1, Fas Ligand, and several chemokines. Similar to IL-1, IL-18 participates in both innate and acquired immunity.

Details
Reactivity Mouse
Sample Volume 50 uL
Suitable Sample Types cell culture supernatant, serum, plasma (citrate)
Sensitivity 10.0 pg/mL
Standard Curve Range 31.3 - 2,000 pg/mL
Components Aluminium pouch(es) with a Microwell Plate coated with monoclonal antibody to mouse IL-18
Biotin-Conjugate anti-mouse IL-18 monoclonal antibody
Streptavidin-HRP
Mouse IL-18 Standard lyophilized, 4 ng/mL upon reconstitution
Sample Diluent
Assay Buffer Concentrate 20x (PBS with 1% Tween 20 and 10% BSA)
Wash Buffer Concentrate 20x (PBS with 1% Tween 20)
Substrate Solution (tetramethyl-benzidine)
Stop Solution (1M Phosphoric acid)
Blue-Dye
Green-Dye
Red-Dye
Adhesive Films
Reported Applications ELISA
Documentation
TDS Link Download TDS
Related Products
Cat. No. Name Excite Emit Application Reg.
BMS6004* Mouse IL-12 p70 Platinum ELISA ELISA RUO
BMS609* Mouse IFN gamma Platinum ELISA (extra sensitive) ELISA RUO
BMS613* Mouse IL-4 Platinum ELISA ELISA RUO
BMS8610FF* Mouse IL-5 FlowCytomix Simplex Multiplex RUO
References

Citations: Zhou,Xiaohong; Li,Feng; Kong,Li; Tomita,Hiroshi; Li,Chao; Cao,Wei. Involvement of Inflammation, Degradation, and Apoptosis in a Mouse Model of Glaucoma. Journal of Biological Chemistry 2005;280:31240-31248. (Link)

Anderson,Michael G.; Nair,K.Saidas; Amonoo,Leslie A.; Mehalow,Adrienne; Trantow,Colleen M.; Masli,Sharmila; John,Simon WM. GpnmbR150X allele must be present in bone marrow derived cells to mediate DBA/2J glaucoma. BMC Genetics 2008;9:30-45. (Link)

References: Takubo,T.; Ohkura,H.; Kumura,T.; Ohta,K.; Yamane,T.; Hino,M.; Kamitani,T.; Tatsumi,N.. Serum IL-18 levels in patients with various hematological disorders. Haematologia (Budap.) 2000;30:31-33. (Link)

Nakamura,H.; Komatsu,K.; Ayaki,M.; Kawamoto,S.; Murakami,M.; Uoshima,N.; Yagi,T.; Hasegawa,T.; Yasumi,M.; Karasuno,T.; Teshima,H.; Hiraoka,A.; Masaoka,T.. Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation. J.Allergy Clin.Immunol. 2000;106:S45-S50. (Link)

Companjen,A.R.; van,der Velden,V; Vooys,A.; Debets,R.; Benner,R.; Prens,E.P.. Human keratinocytes are major producers of IL-18: predominant expression of the unprocessed form 31. Eur.Cytokine Netw. 2000;11:383-390. (Link)

Dinarello,C.A.; Novick,D.; Puren,A.J.; Fantuzzi,G.; Shapiro,L.; Muhl,H.; Yoon,D.Y.; Reznikov,L.L.; Kim,S.H.; Rubinstein,M.. Overview of interleukin-18: more than an interferon-gamma inducing factor. J.Leukoc.Biol. 1998;63:658-664. (Link)

Golab,J.. Interleukin 18--interferon gamma inducing factor--a novel player in tumour immunotherapy? 46. Cytokine 2000;12:332-338. (Link)

Torre,D.; Speranza,F.; Martegani,R.; Pugliese,A.; Castelli,F.; Basilico,C.; Biondi,G.. Circulating levels of IL-18 in adult and paediatric patients with HIV-1 infection. AIDS 2000;14:2211-2212. (Link)

Tsutsui,H.; Matsui,K.; Okamura,H.; Nakanishi,K.. Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol.Rev. 2000;174:192-209. (Link)

Lebel-Binay,S.; Berger,A.; Zinzindohoue,F.; Cugnenc,P.; Thiounn,N.; Fridman,W.H.; Pages,F.. Interleukin-18: biological properties and clinical implications. Eur.Cytokine Netw. 2000;11:15-26. (Link)

Fantuzzi,G.; Dinarello,C.A.. Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J.Clin.Immunol. 1999;19:1-11. (Link)

Gillespie,M.T.; Horwood,N.J.. Interleukin-18: perspectives on the newest interleukin. Cytokine Growth Factor Rev. 1998;9:109-116. (Link)

Xu,D.; Trajkovic,V.; Hunter,D.; Leung,B.P.; Schulz,K.; Gracie,J.A.; McInnes,I.B.; Liew,F.Y.. IL-18 induces the differentiation of Th1 or Th2 cells depending upon cytokine milieu and genetic background. Eur.J.Immunol. 2000;30:3147-3156. (Link)

Ida,A.; Tsuji,Y.; Muranaka,J.; Kanazawa,R.; Nakata,Y.; Adachi,S.; Okamura,H.; Koyama,K.. IL-18 in pregnancy; the elevation of IL-18 in maternal peripheral blood during labour and complicated pregnancies.. J.Reprod.Immunol. 2000;47:65-74. (Link)

Grobmyer,S.R.; Lin,E.; Lowry,S.F.; Rivadeneira,D.E.; Potter,S.; Barie,P.S.; Nathan,C.F.. Elevation of IL-18 in human sepsis. J.Clin.Immunol. 2000;20:212-215. (Link)

Gracie,J.A.; Forsey,R.J.; Chan,W.L.; Gilmour,A.; Leung,B.P.; Greer,M.R.; Kennedy,K.; Carter,R.; Wei,X.Q.; Xu,D.; Field,M.; Foulis,A.; Liew,F.Y.; McInnes,I.B.. A proinflammatory role for IL-18 in rheumatoid arthritis. J.Clin.Invest 1999;104:1393-1401. (Link)

Takubo,T.; Okura,H.; Kumura,T.; Nishiki,S.; Kinoshita,Y.; Koh,K.; Ohta,K.; Yamane,T.; Hino,M.; Kamitani,T.; Tatsumi,N.. Human IL-18 bioactivity in hematological malignancies with highly elevated serum IL-18 levels. Acta Haematol. 2000;103:162-164. (Link)

Pizarro,T.T.; Michie,M.H.; Bentz,M.; Woraratanadharm,J.; Smith,M.F.,Jr.; Foley,E.; Moskaluk,C.A.; Bickston,S.J.; Cominelli,F.. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J.Immunol. 1999;162:6829-6835. (Link)

Monteleone,G.; Trapasso,F.; Parrello,T.; Biancone,L.; Stella,A.; Iuliano,R.; Luzza,F.; Fusco,A.; Pallone,F.. Bioactive IL-18 expression is up-regulated in Crohn's disease. J.Immunol. 1999;163:143-147. (Link)

Endo,S.; Inada,K.; Yamada,Y.; Wakabayashi,G.; Ishikura,H.; Tanaka,T.; Sato,S.. Interleukin 18 (IL-18) levels in patients with sepsis 37. J.Med. 2000;31:15-20. (Link)